A CASE STUDY TO OPTIMIZE FREEZE DRYINGCONDITIONS OF CYCLODEXTRIN-BASED FORMULATIONS
SBECD (Sulfobutylether - β - Cyclodextrin) is a new andpromising excipient for freeze dried formulations. Thepresent study illustrates an approach to optimize freezedrying conditions for formulations containing SBECD.First, a placebo was used to evaluate a general freezedrying recipe. Further, the information gained wascompared with drug product runs.
(PDF) A CASE STUDY TO OPTIMIZE FREEZE DRYING CONDITIONS OF CYCLODEXTRIN-BASED FORMULATIONS. Available from: https://www.researchgate.net/publication/331642211_A_CASE_STUDY_TO_OPTIMIZE_FREEZE_DRYING_CONDITIONS_OF_CYCLODEXTRIN-BASED_FORMULATIONS [accessed Jul 26 2023].
Explicat Pharma GmbH
-
DE
-
2015On CPHI since
-
1 - 24Employees
Other Content from Explicat Pharma GmbH ()
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance